Clinical Trials on Idiopathic Pulmonary Fibrosis With Acute Exacerbation in South Africa
Total 74 results
-
InSilico Medicine Hong Kong LimitedRecruitingIdiopathic Pulmonary Fibrosis (IPF)United States
-
Genentech, Inc.Hoffmann-La RocheCompletedIdiopathic Pulmonary FibrosisUnited States
-
siRNAgen Therapeutics Inc.Active, not recruiting
-
Endeavor Biomedicines, Inc.CompletedIdiopathic Pulmonary FibrosisAustralia
-
FibroGenCompletedIdiopathic Pulmonary FibrosisUnited States, New Zealand, India, South Africa, Australia, Bulgaria, Canada
-
Duke UniversityBoehringer IngelheimRecruitingIdiopathic Pulmonary Fibrosis, Interstitial Lung DiseaseUnited States, Puerto Rico
-
Galecto Biotech ABSyneos Health; bioRASI, LLCCompletedIdiopathic Pulmonary Fibrosis (IPF)United States, Spain, Israel, France, United Kingdom, Australia, Italy, Germany, Canada, Belgium, Georgia, Ireland, Poland, Ukraine
-
Biosplice Therapeutics, Inc.WithdrawnIdiopathic Pulmonary FibrosisAustralia, New Zealand
-
Gilead SciencesTerminatedIdiopathic Pulmonary FibrosisUnited States
-
Algernon PharmaceuticalsCompletedIdiopathic Pulmonary FibrosisAustralia, New Zealand
-
Gilead SciencesCompletedIdiopathic Pulmonary FibrosisUnited States
-
Boehringer IngelheimApproved for marketingIdiopathic Pulmonary FibrosisUnited States
-
Boehringer IngelheimCompletedPulmonary FibrosisArgentina, Australia, Belgium, Brazil, Bulgaria, Canada, Chile, China, Czech Republic, France, Germany, Greece, Hungary, Ireland, Italy, Korea, Republic of, Mexico, Netherlands, Portugal, Russian Federation, South Africa, Spain, Taiwan and more
-
ActelionCompletedIdiopathic Pulmonary FibrosisUnited States, Israel, Spain, Australia, France, Canada, Turkey, Germany, Italy, South Africa, Slovenia, Sweden
-
University of Alabama at BirminghamNational Institutes of Health (NIH)CompletedAmbulatory IPFUnited States
-
Kadmon Corporation, LLCCompletedIdiopathic Pulmonary FibrosisUnited States
-
ImmuneWorksCompletedIdiopathic Pulmonary FibrosisUnited States
-
Pulmonary Fibrosis FoundationUniversity of MichiganCompletedInterstitial Lung Disease (ILD) | Idiopathic Pulmonary Fibrosis (IPF)United States
-
Galapagos NVTerminatedIdiopathic Pulmonary FibrosisUnited States, Netherlands, Korea, Republic of, Israel, Japan, New Zealand, France, Italy, Argentina, Germany, Hungary, South Africa, Poland, Canada, Mexico
-
SanofiCompletedIdiopathic Pulmonary FibrosisSpain, United States, Canada, Chile, Mexico
-
CelgeneTerminatedPathologic Processes | Fibrosis | Respiratory Tract Diseases | Lung Diseases | Idiopathic Pulmonary Fibrosis | Lung Diseases, Interstitial | Idiopathic Interstitial PneumoniasUnited States, Australia, Colombia, United Kingdom, Russian Federation, Brazil, Germany, Canada, Greece, Romania, Taiwan, Turkey, Ukraine
-
University of WashingtonMedical University of South Carolina; Cystic Fibrosis FoundationCompletedCystic Fibrosis | Cystic Fibrosis Pulmonary Exacerbation | Lung InfectionUnited States
-
Toray Industries, IncCompletedIdiopathic Pulmonary FibrosisUnited States
-
Boehringer IngelheimCompletedIdiopathic Pulmonary FibrosisCanada, United States, Netherlands, France, Italy, Germany
-
Boehringer IngelheimCompletedIdiopathic Pulmonary FibrosisUnited States, Canada, Turkey
-
Boehringer IngelheimCompletedIdiopathic Pulmonary FibrosisUnited States, Spain, Korea, Republic of, Canada, Belgium, Australia, United Kingdom, Germany, Italy, France, Japan, Mexico, India
-
Hoffmann-La RocheCompletedIdiopathic Pulmonary FibrosisHungary, Belgium, Germany, Netherlands, Italy, Israel, Spain, Canada, South Africa, Turkey, Czechia, Egypt, Greece
-
MedImmune LLCTerminatedIdiopathic Pulmonary FibrosisUnited States, Australia, Korea, Republic of, Peru, Canada, Israel
-
AmgenActive, not recruitingIdiopathic Pulmonary FibrosisUnited States, Spain, Korea, Republic of, Australia, Japan, Canada, Taiwan, Netherlands, Italy, Chile, Greece, Mexico, Germany, France, Argentina, Poland, Turkey, South Africa, United Kingdom
-
Duke UniversityNational Heart, Lung, and Blood Institute (NHLBI); Duke Clinical Research InstituteTerminatedIdiopathic Pulmonary FibrosisUnited States
-
Centocor, Inc.CompletedPulmonary FibrosisUnited States, Canada, Netherlands, Belgium, Germany
-
ActelionCompletedIdiopathic Pulmonary FibrosisUnited States, France, Spain, Korea, Republic of, Canada, United Kingdom, Australia, Belgium, Netherlands, Japan, Germany, Czech Republic, Italy, Switzerland, Austria, Croatia, Ireland, Israel, Serbia
-
Bristol-Myers SquibbCompletedIdiopathic Pulmonary FibrosisUnited States, Mexico, Australia, Colombia, Chile, Peru
-
Bridge Biotherapeutics, Inc.RecruitingIdiopathic Pulmonary FibrosisUnited States, Korea, Republic of, Australia, Israel, Poland
-
Gilead SciencesTerminatedIdiopathic Pulmonary FibrosisBelgium, France, Germany, Israel, Spain, United States, Switzerland, Colombia, Mexico, Italy, Czech Republic, Australia, Canada, Austria, Poland, United Kingdom, Argentina, Netherlands, Peru, Ireland, Brazil, Chile
-
Boehringer IngelheimCompletedPulmonary FibrosisUnited States, Canada, Chile, China, Finland, France, Germany, Greece, India, Japan, Korea, Republic of, Mexico, Netherlands, Portugal, Russian Federation, Spain, Turkey
-
Pliant Therapeutics, Inc.RecruitingIdiopathic Pulmonary FibrosisUnited States, Australia, Taiwan, Korea, Republic of, Portugal, Germany, Israel, Denmark, New Zealand, Netherlands, Canada, Chile, Czechia, France, Greece, Italy, Poland
-
Hoffmann-La RocheCompletedIdiopathic Pulmonary FibrosisUnited States, Canada, Denmark, France, Germany, Italy, Netherlands, Spain
-
Daewoong Pharmaceutical Co. LTD.RecruitingIdiopathic Pulmonary FibrosisUnited States, Korea, Republic of
-
BiogenTerminatedIdiopathic Pulmonary FibrosisUnited States, Italy, Belgium, Czechia, Russian Federation, Korea, Republic of, Australia, France, Israel, Spain, Poland, Netherlands, Denmark, Greece, Argentina, Chile, United Kingdom
-
Tvardi Therapeutics, IncorporatedRecruitingIdiopathic Pulmonary FibrosisUnited States
-
Endeavor Biomedicines, Inc.CompletedIdiopathic Pulmonary FibrosisCanada, Malaysia, Australia, Mexico, Korea, Republic of
-
Novartis PharmaceuticalsActive, not recruitingIdiopathic Pulmonary FibrosisPoland, Germany, United States, Australia, Czechia, Argentina, Netherlands
-
Pliant Therapeutics, Inc.CompletedIdiopathic Pulmonary FibrosisUnited States, Belgium, Australia, Netherlands, Canada, Italy, New Zealand
-
Boehringer IngelheimCompletedPulmonary FibrosisUnited States, Australia, Belgium, China, Czech Republic, France, Germany, India, Ireland, Israel, Italy, Japan, United Kingdom
-
PureTechActive, not recruitingIdiopathic Pulmonary FibrosisThailand, United States, Korea, Republic of, Philippines, Greece, Georgia, Malaysia, Mexico, Chile, Argentina, Colombia, India, South Africa, Romania
-
Gilead SciencesTerminatedIdiopathic Pulmonary FibrosisUnited States, Spain, Korea, Republic of, Israel, Australia, Italy, Canada, United Kingdom, Switzerland, Germany, Poland, Czechia, Belgium, France
-
Hoffmann-La RocheCompletedIdiopathic Pulmonary FibrosisUnited States, Belgium, Germany, Peru, Mexico, Poland, France, Italy, United Kingdom, Australia, Canada, Spain, Japan
-
Boehringer IngelheimCompletedPulmonary FibrosisSpain, Belgium, Canada, Germany, China, United Kingdom, Australia, Ireland, Italy, Mexico, Netherlands, Portugal, Argentina, France, Russian Federation, Greece, Czechia, Brazil, Bulgaria, Chile, Hungary
-
AceragenWithdrawnCystic Fibrosis | Cystic Fibrosis Pulmonary ExacerbationUnited States